Radiopharma: Delivering a broad portfolio of
PET radiopharmaceuticals to advance patient outcomes
Watch how Radiopharma drives advancements in molecular imaging and supports personalized treatment pathways. (5:04)
Watch how scalable, efficient solutions are offered to third-party drug developers. (4:04)
Theranostics for neuroendocrine tumors: Glenda's journey
Meet Glenda
After receiving the diagnosis of neuroendocrine tumors, Glenda's oncologist was unable to provide effective treatment options. Considering her disease burden and noting the progression of the tumors that were difficult to surgically remove, Glenda was referred to Nebraska Cancer Specialists (NCS) for theranostics treatment. (4:32)
Meet the physicians
Samuel Mehr, MD, director of nuclear oncology and Joel Michalski, MD, PhD, medical oncologist at NCS describe the benefits of offering theranostics within a medical oncology practice and how this creates a patient-centered approach to personalized cancer care for patients like Glenda. (4:17)
Meet the care team
Scott Degenhardt, director of radiology and theranostics, and Marlene Bridwell, theranostics nurse case manager at NCS, highlight the importance of having the right technology and staffing infrastructure in place to help care for patients throughout their theranostics journey. (4:05)
Meet the support team
Navigating the theranostics care pathway requires a high level of coordination and support from a patient's family and healthcare providers. Discover how Glenda's family and care team supported her throughout her theranostics journey. (4:56)
Fully integrated SPECT/CT modernizes facilities to maximize abilities
Watch highlights of how the Baylor Scott & White team transitions from SPECT to SPECT/CT. (1:58)
Watch how the team at Queen Elizabeth Hospital Birmingham is utilizing a new SPECT/CT system. (2:17)